CN Patent

CN103193626B — 一种前列腺素类似物的晶型及其制备方法和用途

Assigned to Shanghai Techwell Biopharmaceutical Co Ltd · Expires 2016-05-11 · 10y expired

What this patent protects

本发明公开了一种结构式如I所示的化合物的晶型B及其制备方法和用途。所述晶型B的X-射线粉末衍射(XRPD)图上在下述2θ角有特征峰：2.9±0.2°，6.5±0.2°，12.6±0.2°，13.1±0.2°和20.6±0.2°。

USPTO Abstract

本发明公开了一种结构式如I所示的化合物的晶型B及其制备方法和用途。所述晶型B的X-射线粉末衍射(XRPD)图上在下述2θ角有特征峰：2.9±0.2°，6.5±0.2°，12.6±0.2°，13.1±0.2°和20.6±0.2°。

Drugs covered by this patent

Patent Metadata

Patent number
CN103193626B
Jurisdiction
CN
Classification
—
Expires
2016-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Techwell Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.